ASH by the Numbers

Whitepaper |

ASH by the Numbers

You can now download ASH by the Numbers – a report on BioCentury’s insights into the emerging targets and top trends in hematology from the 2017 American Society for Hematology (ASH) meeting.

BioCentury’s editorial analysis is based on data from its machine-learning program, run on nearly 5,000 abstracts from the meeting, to find trends and innovation in targets, indications, therapeutic modalities and more, for both pre-clinical and clinical development. Download our collection of articles and understand how they fit into the evolving innovation and treatment landscapes.

Articles include:

Epiphenomena at ASH 
Epigenetics and cell therapies dominate preclinical abstracts at this year’s ASH.

Pathways Emerging from ASH 
BioCentury’s analysis of emerging targets at ASH shows there are more mechanisms at play than immune modulation.

Multimodal Meeting 
Abstracts at ASH hint at how cell and gene therapies will branch out into new indications and fit into evolving treatment landscapes.